Stemgent Starts Scottish Protein Tools Venture

US-based Stemgent will invest around $4.5 million in Ubiquigent, a Scotland-based venture that will make kits and reagents for ubiquitin proteasome pathway research.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.